Phytochemistry Reviews

, Volume 12, Issue 1, pp 121–146 | Cite as

Chrysobalanaceae: secondary metabolites, ethnopharmacology and pharmacological potential

  • Fausto Carnevale Neto
  • Alan Cesar Pilon
  • Vanderlan da Silva Bolzani
  • Ian Castro-Gamboa


Many Chrysobalanaceae species, in special Licania and Parinari, are widely used in folk medicine to treat several diseases. This review describes some aspects of their ethnopharmacology potential, biological activities and the secondary metabolites reported so far for Chrysobalanaceae. The chemical constituents of this family include triterpenoids, diterpenoids, steroids and phenylpropanoids like flavonoids as well as chromones derivatives.


Chrysobalanaceae Kaurane diterpene Glycoside flavonoid Triterpene Ethnopharmacology 


















This work was funded by grants of the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). I. C-G and V.S.B would like to acknowledge CNPq for researcher grants.


  1. Allabi AC, Busia K, Ekanmian V, Bakiono F (2011) The use of medicinal plants in self-care in the Agonlin region of Benin. J Ethopharmacol 133:234–243CrossRefGoogle Scholar
  2. Badisa RB, Chaudhuri SK, Pilarinou E (2000) Licania michauxii Prance root extract induces hsp 70 mRNA and necrotic cell death in cultured human hepatoma and colon carcinoma cell lines. Cancer Lett 149:61–68PubMedCrossRefGoogle Scholar
  3. Barbosa LR, Peres A, Gallori S, Vincieri FF (2006) Determination of myricetin derivatives in Chrysobalanus icaco L. (Chrysobalanaceae). Rev Bras Farmacogn 16:333–337CrossRefGoogle Scholar
  4. Bilia AR, Mendez J, Morelli I (1996a) Phytochemical investigations of Licania genus. Flavonoids and triterpenoids from Licania carii. Pharm Acta Helv 71:191–197CrossRefGoogle Scholar
  5. Bilia AR, Ciampi L, Mendez J, Morelli I (1996b) Phytochemical investigations of Licania genus. Flavonoids from Licania pyrifolia. Pharm Acta Helv 71:199–204CrossRefGoogle Scholar
  6. Bilia AR, Braca A, Mendez J, Morelli I (2000) Molluscicidal and piscicidal activities of Venezuelan Chrysobalanaceae plants. Life Sci 66:53–59Google Scholar
  7. Braca A, Bilia AR, Mendez J, Morelli I (1999a) Three flavonoids from Licania densiflora. Phytochemistry 51:1125–1128CrossRefGoogle Scholar
  8. Braca A, de Tommasi N, Mendez J, Morelli I, Pizza C (1999b) Three flavonoids from Licania heteromorpha. Phytochemistry 51:1121–1124CrossRefGoogle Scholar
  9. Braca A, Morelli I, Mendez J, Battinelli L, Braghiroli L, Mazzanti G (2000) Antimicrobial triterpenoids from Licania heteromorpha. Planta Med 66:768–769PubMedCrossRefGoogle Scholar
  10. Braca A, Bilia AR, Mendez J, Morelli I (2001a) Myricetin glycosides from Licania densiflora. Fitoterapia 72:182–185PubMedCrossRefGoogle Scholar
  11. Braca A, Sortino C, Mendez J, Morelli I (2001b) Triterpenes from Licania licaniaeflora. Fitoterapia 72:585–587PubMedCrossRefGoogle Scholar
  12. Braca A, Luna D, Mendez J, Morelli I (2002a) Flavonoids from Licania apetala and Licania licaniaeflora (Chrysobalanaceae). Biochem Syst Ecol 30:271–273CrossRefGoogle Scholar
  13. Braca A, Sortino C, Politi M, Morelli I, Mendez J (2002b) Antioxidant activity of flavonoids from Licania licaniaeflora. J Ethnopharmacol 79:379–381PubMedCrossRefGoogle Scholar
  14. Braca A, Bilia AR, Mendez J, Pizza C, Morelli I, de Tommasi N (2003) Chemical and biological studies on Licania genus. Stud Nat Prod Chem 28:35–67CrossRefGoogle Scholar
  15. Braca A, Armenise A, Morelli I, Mendez J, Mi Q, Chai H-B, Swanson SM, Kinghorn AD, de Tommasi N (2004) Structure of kaurane-type diterpenes from Parinari sprucei and their potential anticancer activity. Planta Med 70:540–550PubMedCrossRefGoogle Scholar
  16. Braca A, Abdel-Razik AF, Mendez J, Morelli I (2005) A new kaurane diterpene dimer from Parinari campestris. Fitoterapia 76:614–619PubMedCrossRefGoogle Scholar
  17. Carrasco D, Méndez J, Braca A, de Leo M, González-Mujica F, Duque S (2009) Effect of flavonoids from Exellodendron coriaceum (Chrysobalanaceae) on glucose-6-phosphatase. Nat Prod Commun 4:1657–1659PubMedGoogle Scholar
  18. Castilho RO, Kaplan MAC (2008) Constituintes químicos de Licania tomentosa benth. (Chrysobalanaceae). Quim Nova 31:66–69CrossRefGoogle Scholar
  19. Castilho RO, Kaplan MAC (2011) Phytochemical study and antimicrobial activity of Chrysobalanus icaco. Chem Nat Compd 47:436–437CrossRefGoogle Scholar
  20. Castilho RO, de Oliveira RR, Kaplan MAC (2005) Licanolide, a new triterpene lactone from Licania tomentosa. Fitoterapia 76:562–566PubMedCrossRefGoogle Scholar
  21. Chaturvedula VSP, Gao Z, Hecht SM, Jones SH, Kingston DGI (2003) A new acylated oleanane triterpenoid from Couepia polyandra that inhibits the lyase activity of DNA polymerase. J Nat Prod 66:1463–1465CrossRefGoogle Scholar
  22. Chaudhuri SK, Badisa RB, Pilarinou E, Walker EH (2002) Licamichauxiioic-A and -B acids—two ent-kaurene diterpenoids from Licania michauxii. Nat Prod Lett 16:39–45PubMedCrossRefGoogle Scholar
  23. Chitemerere TA, Mukanganyama S (2011) In vitro antibacterial activity of selected medicinal plants from Zimbabwe. Afr J Plant Sci Biotech 5:1–7Google Scholar
  24. Coradin L, Giannasi DE, Prance GT (1985) Chemosystematic studies in the Chrysobalanaceae. I. Flavonoids in Parinari. Brittonia 37:169–178CrossRefGoogle Scholar
  25. de Carvalho MG, da Costa PM (2009) Outros constituintes isolados de Licania arianeae (Chrysobalanaceae). Rev bras Farmacogn 19:290–293CrossRefGoogle Scholar
  26. de Carvalho MG, Cândido LFO, da Costa PM, Rumjanek VM (2005) Chromones from Licania arianeae (Chrysobalanaceae). Nat Prod Res 19:7–12PubMedCrossRefGoogle Scholar
  27. de Carvalho MG, Cândido LFO, da Costa PM, do Nascimento IA, Braz-Filho R (2008) Triterpenes acids and saponins isolated from Licania arianeae Prance (Chrysobalanaceae). J Nat Med 62:360–361PubMedCrossRefGoogle Scholar
  28. Dewick PM (2002) Medicinal natural products: a biosynthetic approach, 2nd edn. Wiley, England, pp 203–211Google Scholar
  29. Enabulele SA, Ehiagbonare JE (2011) Antimicrobial, nutritional and phytochemical properties of Perinari excelsa seeds. Int J Pharm Bio Sci 2:459–470Google Scholar
  30. Estrada O, Alvarado-Castillo C, Fernandez AZ, Lopez M, Romero-Vecchione E, Vasquez J, Mendez J, Conde D, Cardozo A (2009) Pomolic acid isolated from the leaves of Licania pittieri inhibits ADP-and epinephrine-induced platelet aggregation and has hypotensive effect on rats. Curr Bioact Compd 5:219–225CrossRefGoogle Scholar
  31. Estrada O, González-Guzmán JM, Salazar-Bookman M, Fernández AZ, Cardozo A, Alvarado-Castillo C (2011) Pomolic acid of Licania pittieri elicits endothelium-dependent relaxation in rat aortic rings. Phytomedicine 18:464–469PubMedCrossRefGoogle Scholar
  32. Feitosa EA, Xavier HS, Randau KP (2012) Chrysobalanaceae: traditional uses, phytochemistry and pharmacology. Rev Bras Farmacogn. doi: 10.1590/s0102-695x2012005000080
  33. Fernandes J, Castillho RO, da Costa MR, Wagner-Souza K, Kaplan MAC, Gattass CR (2003) Pentacyclic triterpenes from Chrysobalanaceae species: cytotoxicity on multidrug resistant and sensitive leukemia cell lines. Cancer Lett 190:165–169PubMedCrossRefGoogle Scholar
  34. Ferreira-Machado SC, Rodrigues MP, Nunes APM, Dantas FJS, de Mattos JCP, Silva CR, Moura EG, Bezerra RJAC, Caldeira-de-Araujo A (2004) Genotoxic potentiality of aqueous extract prepared from Chrysobalanus icaco L. leaves. Toxicol Lett 151:481–487PubMedCrossRefGoogle Scholar
  35. Garo E, Maillard M, Stoeckli-Evans H, Mavi S, Hostettmann K (1997) Absolute configuration of a diterpene lactone from Parinari capensis. Helv Chim Acta 80:538–544CrossRefGoogle Scholar
  36. Gustafson KR, Munrol MHG, Blunt JW, Cardellina JH II, McMahon JB, Gulakowski RJ, Cragg GM, Cox PA, Brinen LS, Clardy J, Boyd MR (1991) HIV inhibitory natural products. Diterpenes from Homalanthus acuminatus and Chrysobalanus icaco. Tetrahedron 47:4547–4554CrossRefGoogle Scholar
  37. Halilu ME, Agunu A, Ibrahim H, Abdurahman EM (2008) Pharmacognostic evaluation of the stem bark of Parinari curatellifolia planch. Ex benth (Chrysobalanaceae). Niger J Pharm Sci 7:79–85Google Scholar
  38. Hemsing PKB, Romero R (2010) Chrysobalanaceae do parque nacional da Serra da Canastra, Minas Gerais, Brasil. Rodriguésia 61:281–288Google Scholar
  39. Innocent E, Moshi MJ, Masimba PJ, Mbwambo ZH, Kapingu MC, Kamuhabwa A (2009) Screening of traditionally used plants for in vivo antimalarial activity in mice. Afr J Tradit CAM 6:163–167Google Scholar
  40. Karangwa C, Esters V, Fréférich M, Tits M, Kadima JN, Damas J, Noirfalise A, Angenot L (2006) Chemical and biological investigations of a toxic plant from Centra Africa, Magnistipula butayei subsp. montana. J Ethnopharmacol 103:433–438PubMedCrossRefGoogle Scholar
  41. Karangwa C, Esters V, Tits M, Minet A, Boland A, Seutin V, Noirfalise A, Angenot L, Grisar T, Foidart A (2007) Characterization of the neurotoxicity induced by the extract of Magnistipula butayei (Chrysobalanaceae) in rat: effects of a new natural convulsive agent. Toxicon 49:1109–1119PubMedCrossRefGoogle Scholar
  42. Kraft C, Jenett-Siems K, Siems K, Jakupovic J, Mavi S, Bienzle U, Eich E (2003) In vitro antiplasmodial evaluation of medicinal plants from Zimbabwe. Phytother Res 17:123–128 Google Scholar
  43. Lee I-S, Shamon LA, Chai H-B, Chagwedera TE, Besterman JM, Farnsworth NR, Cordell GA, Pezzuto JM, Kinghorn AD (1996) Cell-cycle specific cytotoxicity mediated by rearranged ent-kaurene diterpenoids isolated from Parinari curatellifolia. Chem Biol Interact 99:193–204PubMedCrossRefGoogle Scholar
  44. Lopes LC, de Medeiros FA, de Medeiros AAN (2008) Estudo químico das folhas da espécie Licania macrophylla Benth (Chrysobalanaceae). Revista Pesquisa e Iniciação Cientifica 5:5–6Google Scholar
  45. Mattia CA, Braca A, de Tommasi N, Puliti R (2003) A new norkaurane-γ-lactone from Parinari sprucei. Acta Crystallogr Sect C Cryst Struct Commun 59:644–646CrossRefGoogle Scholar
  46. Mendez J, Billia AR, Morelli I (1995) Phytochemical investigations of Licania genus. Flavonoids and triterpenoids from Licania pittieri. Pharm Acta Helv 70:223–226CrossRefGoogle Scholar
  47. Miranda MMFS, Gonçalves JLS, Romanos MTV, Silva FP, Pinto L, Silva MH, Ejzemberg R, Granja LFZ, Wigg MD (2002) Anti-herpes simplex virus effect of a seed extract from the tropical plant Licania tomentosa (Benth.) Fritsch (Chrysobalanaceae). Phytomedicine 9:641–645PubMedCrossRefGoogle Scholar
  48. Munigunti R, Nelson N, Mulabagal V, Gupta MP, Brun R, Calderón AI (2011) Identification of oleamide in Guatteria recurvisepala by LC/MS-based Plasmodium falciparum thioredoxin reductase ligand binding method. Planta Med 77:1749–1753PubMedCrossRefGoogle Scholar
  49. Ndiaye M, Diatta W, Sy AN, Dièye AM, Faye B, Bassène E (2008) Antidiabetic properties of aqueous barks extract of Parinari excelsa in alloxan-induced diabetic rats. Fitoterapia 79:267–270PubMedCrossRefGoogle Scholar
  50. Oberlies NH, Burgess JP, Navarro HA, Pinos RE, Soejarto DD, Farnsworth NR, Kinghorn AD, Wani MC, Wall ME (2001) Bioactive constituents of the roots of Licania intrapetiolaris. J Nat Prod 64:497–501Google Scholar
  51. Ogbonnia SO, Adekunle A, Olagbende-Dada SA, Anyika EN, Enwuru VN, Orolepe M (2008) Assessing plasma glucose and lipid levels, body weight and acute toxicity following oral administration of an aqueous ethanolic extract of Parinari curatellifolia Planch, (Chrysobalanaceae) seeds in alloxan-induced diabetes in rats. Afr J Biotechnol 7:2998–3003Google Scholar
  52. Prance GT (2007) Flora da reserva Ducke, Amazonas, Brasil: Chrysobalanaceae. Rodriguésia 58:493–531Google Scholar
  53. Sanduja R, Alam M, Euler KL (1983) Contituents of Couepia paraensis. J Nat Prod 46:149PubMedCrossRefGoogle Scholar
  54. Sawadogo WR, Maciuk A, Banzouzi JT, Champy P, Figadère B, Guissou IP, Nacoulma OG (2011a) Mutagenic effect, antioxidant and anticancer activities of six medicinal plants from Burkina Faso. Nat Prod Res. doi: 10.1080/14786419.2010.534737
  55. Sawadogo WR, Le Douaron G, Maciuk A, Bories C, Loiseau PM, Figadère B, Guissou IP, Nacoulma OG (2011b) In vitro antileishmanial and antitrypanosomal activities of five medicinal plants from Burkina Faso. Parasitol Res. doi: 10.1007/s00436-011-2699-3
  56. Suffness M, Abbott B, Statz D, Wonilowicz E, Spjut R (1988) The utility of P388 leukemia compared to B16 melanoma and colon carcinoma 38 for in vivo screening of plants extracts. Phytother Res 2:89–97Google Scholar
  57. Uys ACU, Malan SF, Van Dyk S, Van Zyl RL (2002) Antimalarial compounds from Parinari capensis. Bioorg Med Chem Lett 12:2167–2169PubMedCrossRefGoogle Scholar
  58. Van der Burgt XM (2010) Two new taxa in Magnistipula (Chrysobalanaceae) from Korup National Park, Cameroon. Plant Ecol Evol 143:191–198CrossRefGoogle Scholar
  59. Vargas CE, Mendes MF, Azevedo DA, Pessoa FLP, Uller AC (2010) Extraction of the essential oil of abajeru (Chrysobalanus icaco) using supercritical CO2. J Supercrit Fluids 54:171–177CrossRefGoogle Scholar
  60. Vásquez J, Mendes J, Romero VE, Rosa F, Estrada O (1995) Principios activos con acción cardiovascular del extracto metanólico de las ramas de Licania pittieri. Acta Cient Venez 46:82Google Scholar
  61. Werawattanachai N, Kaewamatawong R (2010) Chemical constituents from Parinari anamense. Biochem Syst Ecol 38:836–838CrossRefGoogle Scholar
  62. Yakandawala D, Morton CM, Prance GT (2010) Phylogenetic relationships of the Chrysobalanaceae inferred from chloroplast, nuclear, and morphological data. Ann Mo Bot Gard 97:259–281CrossRefGoogle Scholar
  63. Zuque ALF, Watanabe ES, Ferreira AMT, Arruda ALA, Resende UM, Bueno NR, Castilho RO (2004) Avaliação das atividades antioxidante, antimicrobiana e citotóxica de Couepia grandiflora Benth. (Chrysobalanaceae). Rev Bras Farmacogn 14:129–136CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Fausto Carnevale Neto
    • 1
  • Alan Cesar Pilon
    • 1
  • Vanderlan da Silva Bolzani
    • 1
  • Ian Castro-Gamboa
    • 1
  1. 1.Department of Organic Chemistry, Chemistry Institute, Nucleus of Bioassays, Biosynthesis and Ecophysiology of Natural Products, NuBBESão Paulo State University, UNESPAraraquaraBrazil

Personalised recommendations